North America Contract Research Organization (CRO) Market, Size, Segment and Growth by Forecast Period: (2021-2031)
The North America contract research organization (CRO) market is expected to reach US$ 30.7 Bn in 2025 from US$ 16.3 Bn in 2017. The market is estimated to grow with a CAGR of 8.4% from 2018-2025.
The growth of the Contract
Research Organization (CRO) market is driven by the factors such as,
increasing R&D expenditures and outsourcing activities and rise in the
number of clinical trials. However, the market is likely to get impacted due to
dearth of skilled professionals and regional competition in the CRO services
market, in the region.
๐Download Full PDF Sample
Copy of Market Report @
https://wwcw.businessmarketinsights.com/sample/TIPRE00004300
Pharmaceutical and biotech companies are focusing on the
research and development (R&D) to come up with new molecules for various
therapeutic applications with the greatest medical and commercial potential.
The companies invest majorly on the R&Ds with the aim of delivering high
quality and innovative products to the market. R&D spending by the
biopharmaceutical companies has also increased over the years. According to a
report of Pharmaceutical Research and Manufacturers of America (PhRMA), the
R&D expenditure of the biopharmaceutical companies has increased from US$
49.6 Bn 2012 to US$ 58.8 Bn in 2015. Research and development expenditures
relate to the processes of discovering, testing and developing new products,
upfront payments and milestones, improving existing products, as well as
demonstrating product efficacy and regulatory compliance prior to launch.
According to the International Federation of Pharmaceutical Manufacturers &
Associations, the R&D expenditures in 2014 by the pharmaceuticals and biotechnology
industry grew by approximately 8.7% than that of the expenditures in 2013.
Moreover, in United States, investments for R&D by pharmaceutical companies
had grown consistently over the last 15 years. The intensity for R&D by the
companies in Japan accounted for about 13.3%, in US it accounted approximately
17% and in the European Union it was registered to be approximately 13% in the
year 2014. Therefore, the pharmaceutical and biotech companies prefer to
outsource the services to the contract research organizations (CROs) in order
to save the cost and time which is expected to drive the growth of the market.
US is expected to lead the market in the North America
region owing to increasing expenditure of research and development expenditures
in the country. The confrontation of biotechnology and pharmaceutical companies
to lower the drug development costs is expected to propel the CROs market in
the US. Moreover, the presence of top revenue generating pharmaceutical
companies in the US that have capability to invest a large amount in R&D is
also expected to boost the growth of CROs in the US. Therefore, considering the
above mentioned factors the growth of the market in the country is likely to
contribute largest share in the North America region during the forecast
period.
North America Contract Research Organization (CRO)
Strategic Insights
Strategic insights for the North America Contract Research
Organization (CRO) provides data-driven analysis of the industry landscape,
including current trends, key players, and regional nuances. These insights
offer actionable recommendations, enabling readers to differentiate themselves
from competitors by identifying untapped segments or developing unique value
propositions. Leveraging data analytics, these insights help industry players
anticipate the market shifts, whether investors, manufacturers, or other
stakeholders. A future-oriented perspective is essential, helping stakeholders
anticipate market shifts and position themselves for long-term success in this
dynamic region. Ultimately, effective strategic insights empower readers to
make informed decisions that drive profitability and achieve their business
objectives within the market.
key company profiles
IQVIA
Laboratory
Corporation of America Holdings
PAREXEL
International Corporation
ICON plc
Syneos Health
PRA Health Sciences
Charles River
Pharmaceutical
Product Development, LLC
WuXi AppTec
Medpace
North America Contract Research Organization (CRO) Regional Insights
The geographic scope of the North America Contract Research
Organization (CRO) refers to the specific areas in which a business operates
and competes. Understanding local distinctions, such as diverse consumer
preferences (e.g., demand for specific plug types or battery backup durations),
varying economic conditions, and regulatory environments, is crucial for
tailoring strategies to specific markets. Businesses can expand their reach by
identifying underserved areas or adapting their offerings to meet local
demands. A clear market focus allows for more effective resource allocation,
targeted marketing campaigns, and better positioning against local competitors,
ultimately driving growth in those targeted areas.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Dรฉfense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author's Bio
Akshay
Senior Market Research Expert at Business Market Insights
Comments
Post a Comment